台股 » 個股 » 生展 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生展

(8279)
  • 股價
    158.5
  • 漲跌
    ▼1.5
  • 漲幅
    -0.94%
  • 成交量
    10
  • 產業
    上櫃 生技醫療類股
  • 67人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生展 (8279)籌碼相關-凱基-內埔 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-內埔 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/03/251156.0000.00161.001109.23%
2024/03/2000.001159.50158.50-110-9.48%
2023/09/190.1170.0000.00170.000.1130.38%
2023/06/2900.001173.00173.00-152-1.92%
2023/06/121171.0000.00171.501531.87%
2023/05/261185.0000.00185.001611.62%
2023/05/2500.001190.00191.50-161-1.62%
2023/05/111177.001180.00178.500600.00%
2023/05/040.1184.0000.00185.000.1580.09%
2023/05/0200.000.1186.00185.00-0.155-0.09%
2023/04/281193.001196.00191.000540.00%
2023/04/251184.001187.00177.000510.00%
2023/04/201179.0000.00180.001492.04%
2023/04/180.1180.0000.00180.000.1470.10%
2023/04/1700.001181.00181.00-147-2.12%
2023/02/2300.001167.00166.00-158-1.72%
2023/01/101156.5000.00154.001681.46%
2022/12/271162.0000.00163.001711.41%
2022/12/261171.002173.25171.00-169-1.44%
2022/12/2300.001164.00165.50-163-1.57%
2022/12/201153.0000.00154.501621.61%
2022/12/1900.001157.00156.00-161-1.62%
2022/11/251137.5000.00138.001681.46%
2022/11/181146.0000.00143.501751.33%
2022/11/1700.003144.50149.50-374-4.01%
2022/11/101136.0000.00136.001811.22%
2022/10/131145.0000.00143.0011040.96%
2022/10/0500.001158.00159.50-1101-0.98%
2022/10/0400.001152.00154.00-1102-0.97%
2022/09/281147.5000.00141.5011030.97%
2022/09/271146.501150.00151.0001010.00%
2022/09/221160.0000.00160.0011030.97%
2022/09/131162.0000.00161.501991.01%
2022/09/081174.0000.00172.001941.06%
2022/08/2200.001.1172.13170.00-1.181-1.40%
2022/08/1800.000.1160.50160.00-0.174-0.13%
2022/08/1000.001.2142.90146.00-1.256-2.12%
2022/07/281136.001136.50136.000490.00%
2022/06/0100.000.1132.00132.00-0.137-0.13%
2022/05/181124.001126.00127.500410.00%
2022/04/1800.000131.00129.500670.00%
2022/04/010120.001121.00124.00-167-1.47%
2022/03/2900.001126.00122.50-169-1.45%
2022/02/251121.0000.00121.501711.40%
2022/02/221125.0000.00124.501691.44%
2022/02/170129.0000.00130.500680.07%
2022/02/080.1130.0000.00130.000.1630.16%
2022/01/2500.004126.00128.00-456-7.03%
2022/01/211125.501126.50126.000470.00%
2022/01/071111.0000.00113.001313.19%
2021/09/08189.0000.0088.101392.55%
2021/09/061.188.6400.0089.001.1392.77%
2021/08/30189.5000.0090.201432.29%
2021/08/200.190.0000.0089.900.1420.23%
2021/08/170.290.0000.0090.500.2420.35%
2021/07/271101.0000.00100.501372.66%
2021/07/261101.0000.00101.501372.63%
2021/04/280.2115.0000.00116.000.2490.30%
2019/06/1700.000.1126.00126.50-0.147-0.21%
2019/06/1400.002125.50126.50-248-4.13%
2019/02/1500.001105.00104.50-124-4.06%
2019/01/281102.0000.00106.001234.21%
2018/07/251120.0000.00121.0011140.87%
2018/06/271140.5000.00140.5012650.38%
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
〈聯合再生展望〉洪傳獻:TOPCon技術明年成主流 獲利表現佳Anue鉅亨-2023/10/16
生展 相關文章